Trends in the lifetime risk of COPD exacerbation requiring hospitalisation

European Respiratory Journal

Volumn 42, Issue 4, 2013, Pages 964-971

  Lykkegaard, Jesper ^a   De Pont Christensen, René ^a   Davidsen, Jesper Rømhild ^a,b   Støvring, Henrik ^c   Andersen, Morten ^a,d   Søndergaard, Jens ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DENMARK; DISEASE EXACERBATION; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; TREND STUDY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; DENMARK; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RETROSPECTIVE STUDIES; RISK; SEX FACTORS; SURVIVAL RATE;

EID: 84886497997     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00129312     Document Type: Article

References (28)

1. Kohansal R, Martinez-Camblor P, Agusti A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009; 180: 3-10.
2. Keiding N. Age-specific incidence and prevalence - a statistical perspective. J Royal Statist Soc Series A 1991; 154: 371-412.
3. Sasieni PD, Shelton J, Ormiston-Smith N, et al. What is the lifetime risk of developing cancer? The effect of adjusting for multiple primaries. Br J Cancer 2011; 105: 460-465.
4. Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular disease. N Engl J Med 2012; 366: 321-329.
5. Paap E, Broeders MJ, van Schoor G, et al. Large increase in a Dutch woman's lifetime risk of developing breast cancer. Eur J Cancer 2008; 44: 1485-1487.
6. Gershon AS, Warner L, Cascagnette P, et al. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet 2010; 378: 991-996.
7. van Durme YMTA, Verhamme KMC, Stijnen T, et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly. Chest 2009; 135: 368-377.
8. Afonso AS, Verhamme KM, Sturkenboom MC, et al. COPD in the general population: prevalence, incidence and survival. Respir Med 2011; 105: 1872-1884.
9. Price LC, Lowe D, Hosker HSR, et al. UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax 2006; 61: 837-842.
10. Jansson SA, Andersson F, Borg S, et al. Costs of COPD in Sweden according to disease severity. Chest 2002; 122: 1994-2002.
11. Bastin AJ, Starling L, Ahmed R, et al. High prevalence of undiagnosed and severe chronic obstructive pulmonary disease at first hospital admission with acute exacerbation. Chron Respir Dis 2010; 7: 91-97.
12. Garcia-Aymerich J, Serra Pons I, Mannino DM, et al. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax 2011; 66: 585-590.
13. Statistics Denmark. Population in Denmark. www.dst.dk/en/Statistik/emner/ befolkning-og-befolkningsfremskrivning/ folketal.aspx Date last accessed: April 25, 2013.
14. Thomsen RW, Lange P, Hellquist B, et al. Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med 2011; 105: 1063-1068.
15. World Health Organization. International Classification of Diseases, 10th Revision. www.who.int/classifications/ icd/en/ Date last accessed: April 25, 2013.
16. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011; 39: 22-25.
17. Lykkegaard J, Sondergaard J, Kragstrup J, et al. All Danish first-time COPD hospitalisations 2002-2008: incidence, outcome, patients, and care. Respir Med 2012; 106: 549-556.
18. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004; 59: 387-395.
19. Organization for Economic Cooperation and Development Health Division. OECD Health Data 2006. www.oecd. org/dataoecd/20/51/37622205.xls Date last accessed: April 25, 2013.
20. Brown DW, Croft JB, Greenlund KJ, et al. Trends in hospitalization with chronic obstructive pulmonary disease- United States, 1990-2005. COPD 2010; 7: 59-62.
21. Kabir Z, Connolly GN, Koh HK, et al. Chronic obstructive pulmonary disease hospitalization rates in Massachusetts: a trend analysis. QJM 2010; 103: 163-168.
22. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Respir Care 2002; 47: 1184-1199.
23. Liaaen ED, Henriksen AH, Stenfors N. A Scandinavian audit of hospitalizations for chronic obstructive pulmonary disease. Respir Med 2010; 104: 1304-1309.
24. Fuhrman C, Roche N, Vergnenegre A, et al. Hospital admissions related to acute exacerbations of chronic obstructive pulmonary disease in France, 1998-2007. Respir Med 2011; 105: 595-601.
25. American Lung Association. The Scope of COPD in Illinois - Executive Summary. www.lung.org/associations/ states/illinois/assets/pdfs/scope-of-copd- summary-2011.pdf Date last accessed: April 25, 2013. Date last updated: March 2011.
26. Christensen K, Doblhammer G, Rau R, et al. Ageing populations: the challenges ahead. Lancet 2009; 374: 1196-1208.
27. Madsen M, Videbæk J. Heart Statistics 2004. Copenhagen, Danish National Institute of Public Health, 2004.
28. Lykkegaard J, Davidsen JR, Paulsen MS, et al. On the crest of a wave: Danish prevalence of hospitalisation-required COPD 2002-2009. Respir Med 2012; 106: 1396-1403.